If you’re an adult who is experiencing symptoms of major depressive disorder, such as persistent sadness, low energy, or a loss of interest in activities you once enjoyed, you may be eligible for one of two psychedelic clinical research studies currently enrolling at Catalina Research Institute in Montclair, CA.
If you’re an adult who is experiencing symptoms of major depressive disorder, such as persistent sadness, low energy, or a loss of interest in activities you once enjoyed, you may be eligible for one of two psychedelic clinical research studies currently enrolling at Catalina Research Institute in Montclair, CA.
If you’re an adult who is experiencing symptoms of major depressive disorder, such as persistent sadness, low energy, or a loss of interest in activities you once enjoyed, you may be eligible for one of two psychedelic clinical research studies currently enrolling at Catalina Research Institute in Montclair, CA.
Major depressive disorder (MDD), also known as clinical depression, is a common but serious mental health condition that affects how a person feels, thinks, and functions in daily life. Unlike occasional sadness, MDD involves a persistent low mood, a loss of interest in activities once enjoyed, and noticeable changes in sleep, appetite, and energy levels.
MDD can significantly impact a person’s quality of life, often interfering with work, school, relationships, and everyday responsibilities. Researchers are evaluating new ways to help treat adults with major depression.
Adults 18 and older experiencing symptoms of major depressive disorder (MDD) may qualify for one of two research studies testing innovative psychedelic treatments with psilocybin or DMT. Study enrollment offers access to potential therapies not yet available to the public, with all study-related care provided at no cost.
By joining, you’ll receive healthcare services from a dedicated team of specialists focused on your well-being, while helping shape the future of mental health research and offering new hope to others living with depression.
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.